Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study-Reference-Cited by-同舟云学术

Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study

Published:2023-07-01 Issue:7 Volume:25 Page:476-484
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

McCarthy Olivia M.¹²^ORCID,Christensen Merete B.²,Kristensen Kasper Birch²,Schmidt Signe²^ORCID,Ranjan Ajenthen G.²³,Bain Stephen C.⁴,Bracken Richard M.¹,Nørgaard Kirsten²⁵

Affiliation:

1. Applied Sport, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, United Kingdom.

2. Copenhagen University Hospital—Steno Diabetes Center Copenhagen, Herlev, Denmark.

3. Danish Diabetes Academy, Odense, Denmark.

4. Medical School, Swansea University, Swansea, United Kingdom.

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0009

Reference22 articles.

1. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

2. Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users

3. One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

4. Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus

5. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System;Diabetes Technology & Therapeutics;2024-03-01

2. Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted;The Journal of Clinical Endocrinology & Metabolism;2024-02-08